Risk of oxalate nephropathy with the use of cyanide antidote hydroxocobalamin in critically ill burn patients

被引：31

作者：

Legrand, Matthieu ^{[1
,2
,3
,4
]}

Michel, Thibault ^{[1
,2
]}

Daudon, Michel ^{[5
,6
]}

Benyamina, Mourad ^{[1
,2
]}

Ferry, Axelle ^{[1
,2
]}

Soussi, Sabri ^{[1
,2
]}

Maurel, Veronique ^{[1
,2
]}

Chaussard, Maite ^{[1
,2
]}

Chaouat, Marc ^{[3
,7
]}

Mimoun, Maurice ^{[3
,7
]}

Verine, Jerome ^{[3
,8
]}

Mallet, Vincent ^{[9
]}

Mebazaa, Alexandre ^{[1
,2
,3
,4
]}

机构：

[1] Hop St Louis, AP HP, Dept Anaesthesiol & Crit Care, F-75010 Paris, France

[2] Hop St Louis, AP HP, Burn Unit, F-75010 Paris, France

[3] Univ Paris Diderot, Paris, France

[4] INSERM, U942, F-75475 Paris, France

[5] Hop Tenon, AP HP, Lab Lithiases, Serv Explorat Fonct Multidisciplinaires, F-75020 Paris, France

[6] UPMC, Univ Sorbonne, INSERM, UMR S 1155, F-75020 Paris, France

[7] Hop St Louis, AP HP, Plast Surg, F-75010 Paris, France

[8] Hop St Louis, AP HP, Dept Pathol, F-75010 Paris, France

[9] Univ Paris 05, Grp Hosp Cochin Port Royal, AP HP, Inst Pasteur,Serv Hepatol,Unite Mixte Serv 020, Paris, France

来源：

INTENSIVE CARE MEDICINE | 2016年 / 42卷 / 06期

关键词：

SMOKE-INHALATION;

D O I：

10.1007/s00134-016-4252-4

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：1080 / 1081

页数：2

共 50 条

[1] Risk of oxalate nephropathy with the use of cyanide antidote hydroxocobalamin in critically ill burn patients
Matthieu Legrand
Thibault Michel
Michel Daudon
Mourad Benyamina
Axelle Ferry
Sabri Soussi
Véronique Maurel
Maïte Chaussard
Marc Chaouat
Maurice Mimoun
Jérôme Verine
Vincent Mallet
Alexandre Mebazaa
Intensive Care Medicine, 2016, 42 : 1080 - 1081
[2] Seven Years of Cyanide Ingestions in the US - Critically Ill Patients Are Common, but Antidote Use Is Not
Bebarta, V. S.
Pitotti, R.
Morgan, D. L.
Borys, D.
CLINICAL TOXICOLOGY, 2009, 47 (07) : 753 - 753
[3] Seven years of cyanide ingestions in the USA: critically ill patients are common, but antidote use is not
Bebarta, Vikhyat S.
Pitotti, Rebecca L.
Borys, Doug J.
Morgan, David L.
EMERGENCY MEDICINE JOURNAL, 2011, 28 (02) : 155 - 158
[4] Patterns of Cyanide Antidote Use Since Regulatory Approval of Hydroxocobalamin in the United States
Streitz, Matthew J.
Bebarta, Vikhyat S.
Borys, Douglas J.
Morgan, David L.
AMERICAN JOURNAL OF THERAPEUTICS, 2014, 21 (04) : 244 - 249
[5] SAFETY AND EFFICACY OF HYDROXOCOBALAMIN IN CRITICALLY ILL VASOPLEGIC PATIENTS
Li, Fanny
Edna, Miao
Kang, Kara
Wilson, Li
Thornton, Kevin
Bouajram, Rima
CRITICAL CARE MEDICINE, 2019, 47
[6] Safety of hydroxocobalamin use in the Prehospital setting as an antidote for smoke inhalation associated cyanide poisoning
Baud, F.
Borron, S.
ANNALS OF EMERGENCY MEDICINE, 2006, 48 (04) : S55 - S55
[7] Interference of the cyanide antidote hydroxocobalamin with carboxyhemoglobin measurements should not limit clinical use in suspected or confirmed cyanide poisoning
Borron, Stephen W.
Uhl, Wolfgang
Nolting, Arno
Hostalek, Ulrike
Serono, Merck
ANNALS OF EMERGENCY MEDICINE, 2007, 50 (05) : 624 - 625
[8] Hydroxocobalamin-attributed risk of oxalate nephropathy: evidence is not sufficient to change the recommended management of cyanide toxicity by fire smoke inhalation
Megarbane, Bruno
INTENSIVE CARE MEDICINE, 2016, 42 (07) : 1197 - 1198
[9] Hydroxocobalamin-attributed risk of oxalate nephropathy: evidence is not sufficient to change the recommended management of cyanide toxicity by fire smoke inhalation
Bruno Mégarbane
Intensive Care Medicine, 2016, 42 : 1197 - 1198
[10] Infections in critically ill burn patients
Hidalgo, F.
Mas, D.
Rubio, M.
Garcia-Hierro, P.
MEDICINA INTENSIVA, 2016, 40 (03) : 179 - 185

← 1 2 3 4 5 →